These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 8643939

  • 1. [Fulminant, rapidly reversible hepatitis and life-threatening anaphylaxis following rifampicin in an HIV-positive female patient with latent adrenal cortex insufficiency].
    Canova CR, Kuhn M, Zellweger U, Reinhart WH.
    Schweiz Med Wochenschr; 1996 Mar 09; 126(10):392-7. PubMed ID: 8643939
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Case of fatal liver failure due to anti-tuberculous therapy].
    Harada Y, Kawakami K, Koyama K, Yamaryo T, Kimura Y.
    Kekkaku; 2007 Sep 09; 82(9):705-9. PubMed ID: 17969987
    [Abstract] [Full Text] [Related]

  • 6. [A case of pulmonary tuberculosis with acute renal failure caused by readministration of rifampicin].
    Kuroda F, Yagi T, Yamagishi F, Mizutani F, Sasaki Y, Wada A.
    Kekkaku; 1999 Nov 09; 74(11):803-7. PubMed ID: 10599213
    [Abstract] [Full Text] [Related]

  • 7. Shock and cerebral infarct after rifampin re-exposure in a patient infected with human immunodeficiency virus.
    Martínez E, Collazos J, Mayo J.
    Clin Infect Dis; 1998 Nov 09; 27(5):1329-30. PubMed ID: 9827298
    [No Abstract] [Full Text] [Related]

  • 8. [A case of partial Addison's disease activated with the administration of rifampicin (RFP)].
    Okudaira S, Shimoji K, Yogi Y, Yara S, Saito A.
    Kekkaku; 1999 Feb 09; 74(2):115-20. PubMed ID: 10191604
    [Abstract] [Full Text] [Related]

  • 9. Rifampicin plus pyrazinamide versus isoniazid for treating latent tuberculosis infection: a meta-analysis.
    Gao XF, Wang L, Liu GJ, Wen J, Sun X, Xie Y, Li YP.
    Int J Tuberc Lung Dis; 2006 Oct 09; 10(10):1080-90. PubMed ID: 17044199
    [Abstract] [Full Text] [Related]

  • 10. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov 09; 78(11):717-22. PubMed ID: 14672050
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetic interaction between rifampicin and the once-daily combination of saquinavir and low-dose ritonavir in HIV-infected patients with tuberculosis.
    Ribera E, Azuaje C, Lopez RM, Domingo P, Curran A, Feijoo M, Pou L, Sánchez P, Sambeat MA, Colomer J, Lopez-Colomes JL, Crespo M, Falcó V, Ocaña I, Pahissa A.
    J Antimicrob Chemother; 2007 Apr 09; 59(4):690-7. PubMed ID: 17307771
    [Abstract] [Full Text] [Related]

  • 12. Deleterious influence of pyrazinamide on the outcome of patients with fulminant or subfulminant liver failure during antituberculous treatment including isoniazid.
    Durand F, Bernuau J, Pessayre D, Samuel D, Belaiche J, Degott C, Bismuth H, Belghiti J, Erlinger S, Rueff B.
    Hepatology; 1995 Apr 09; 21(4):929-32. PubMed ID: 7705802
    [Abstract] [Full Text] [Related]

  • 13. [Stevens-Johnson syndrome and toxic epidermal necrolysis after intake of rifampicin-isoniazid: report of 8 cases in HIV-infected patients in Togo].
    Pitche P, Mouzou T, Padonou C, Tchangai-Walla K.
    Med Trop (Mars); 2005 Sep 09; 65(4):359-62. PubMed ID: 16548490
    [Abstract] [Full Text] [Related]

  • 14. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H, Namba K.
    Kekkaku; 2006 Dec 09; 81(12):753-74. PubMed ID: 17240921
    [Abstract] [Full Text] [Related]

  • 15. [Acute rifampicin-induced adrenal insufficiency].
    Lorente R, Ampudia-Blasco FJ, Catalá M, Carmena R.
    Rev Clin Esp; 1997 Oct 09; 197(10):725-6. PubMed ID: 9424678
    [No Abstract] [Full Text] [Related]

  • 16. [A case of agranulocytosis caused by rifampicin during treatment of tuberculous lymphadenitis in a chronic renal failure patient].
    Sugiyama M.
    Kekkaku; 2012 Nov 09; 87(11):719-25. PubMed ID: 23367831
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Specific features of acute renal failure in patients treated with rifampicin].
    Munteanu L, Golea O, Nicolicioiu M, Tudorache V.
    Pneumologia; 2002 Nov 09; 51(1):15-20. PubMed ID: 12043271
    [Abstract] [Full Text] [Related]

  • 20. [Severe hepatotoxicity of tuberculostatic agents. Increase in the incidence].
    Moitinho E, Salmerón JM, Mas A, Bruguera M, Rodés J.
    Gastroenterol Hepatol; 1996 Nov 09; 19(9):448-51. PubMed ID: 8998667
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.